These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25755404)

  • 1. Perioperative bacterial infections in deceased donor and living donor liver transplant recipients.
    Varghese J; Gomathy N; Rajashekhar P; Venugopal K; Olithselvan A; Vivekanandan S; Naresh S; Sujatha C; Vijaya S; Jayanthi V; Rela M
    J Clin Exp Hepatol; 2012 Mar; 2(1):35-41. PubMed ID: 25755404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.
    Yankol Y; Bugeaud E; Zens T; Rizzari M; Mecit N; Leverson GE; Foley D; Mezrich JD; Kanmaz T; Andaçoğlu OM; D'Alessandro AM; Acarlı KS; Kalayoğlu M; Fernandez LA
    Turk J Med Sci; 2021 Apr; 51(2):610-622. PubMed ID: 33037873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.
    Wan P; Yu X; Xia Q
    Liver Transpl; 2014 Apr; 20(4):425-36. PubMed ID: 24478109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation.
    Merion RM; Shearon TH; Berg CL; Everhart JE; Abecassis MM; Shaked A; Fisher RA; Trotter JF; Brown RS; Terrault NA; Hayashi PH; Hong JC;
    Ann Surg; 2010 Mar; 251(3):542-9. PubMed ID: 20130466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
    Chen LP; Li C; Wen TF; Yan LN; Li B; Yang JY
    Pak J Med Sci; 2015; 31(4):763-9. PubMed ID: 26430399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing High- and Low-Model for End-Stage Liver Disease Living-Donor Liver Transplantation to Determine Clinical Efficacy: A Systematic Review and Meta-Analysis (CHALICE Study).
    Jayant K; Cotter TG; Reccia I; Virdis F; Podda M; Machairas N; Arasaradnam RP; Sabato DD; LaMattina JC; Barth RN; Witkowski P; Fung JJ
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.
    Humar A; Ganesh S; Jorgensen D; Tevar A; Ganoza A; Molinari M; Hughes C
    Ann Surg; 2019 Sep; 270(3):444-451. PubMed ID: 31305283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should We Exclude Live Donor Liver Transplantation for Liver Transplant Recipients Requiring Mechanical Ventilation and Intensive Care Unit Care?
    Goldaracena N; Spetzler VN; Sapisochin G; J E; Moritz K; Cattral MS; Greig PD; Lilly L; McGilvray ID; Levy GA; Ghanekar A; Renner EL; Grant DR; Selzner M; Selzner N
    Transplant Direct; 2015 Sep; 1(8):e30. PubMed ID: 27500230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recipient Survival among Living Donor vs. Deceased Donor Liver Transplants for Acute Liver Failure in the United States.
    Moughames E; Gurakar M; Khan A; Alsaqa M; Ozturk NB; Bonder A; Gurakar A; Saberi B
    J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541954
    [No Abstract]   [Full Text] [Related]  

  • 12. Does living donation have advantages over deceased donation in liver transplantation?
    Kaido T; Uemoto S
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1598-603. PubMed ID: 20880167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients.
    Shen B; Chen B; Zhang W; Mao H; Shen C; Deng X; Zhan X; Chen H
    Liver Transpl; 2009 Nov; 15(11):1473-80. PubMed ID: 19877254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
    Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
    Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database.
    Yadav AD; Chang YH; Aqel BA; Byrne TJ; Chakkera HA; Douglas DD; Mulligan DC; Rakela J; Vargas HE; Carey EJ
    J Transplant; 2013; 2013():269096. PubMed ID: 24205434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of infection on post-transplant outcomes: living versus deceased donor liver transplants.
    Siddique O; Siddique AS; Machan JT; Promrat K
    Clin Exp Hepatol; 2018 Mar; 4(1):28-34. PubMed ID: 29594195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
    Reichman TW; Katchman H; Tanaka T; Greig PD; McGilvray ID; Cattral MS; Renner EL; Selzner M; Ghanekar A; Levy G; Grant DR
    Transpl Int; 2013 Aug; 26(8):780-7. PubMed ID: 23746118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.
    Goldberg DS; Ruebner RL; Abt PL
    Am J Transplant; 2015 Oct; 15(10):2732-8. PubMed ID: 25969133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for hepatocellular carcinoma from living-donor
    Akamatsu N; Kokudo N
    Hepatobiliary Surg Nutr; 2016 Oct; 5(5):422-428. PubMed ID: 27826557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single-Center Analysis.
    Leung KK; Kim A; Hansen BE; Lilly L; Selzner N; Patel K; Bhat M; Hirschfield GM; Galvin Z
    Liver Transpl; 2021 Dec; 27(12):1733-1746. PubMed ID: 34092028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.